Latest Period
Q2 2026
Security Snapshot
Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share (VNDA) Institutional Ownership
CUSIP: 921659108
13F Institutional Holders and Ownership History from Q1 2014 to Q2 2026
Institutions Reporting
169
Shares (Excl. Options)
49,673,607
Price
$6.12
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Symbol
- VNDA on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 49,673,607
- Total 13F value
- $303,993,447
- Portfolio coverage rank
- 0%
- Share change
- +3,126,917
- Value change
- +$17,548,114
- Number of holders
- 169
- Shares outstanding
- 60,292,875
- SEC-reported price per share
- $5.85
- Insider filing price
- $5.85
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- VNDA - Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share is tracked under CUSIP 921659108.
- 169 institutions reported positions in Q2 2026.
- 5 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 170 to 169 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $319,434,847 to $303,993,447.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 169 institutions filings for Q2 2026.
Security key
921659108
Latest holder period
Q2 2026
13F holders
169
13D/G owners
5
CIK / CUSIP context first
Open Q2 2026 holders
VNDA full holder history
Vanda Pharmaceuticals Inc. SEC filings
Vanda Pharmaceuticals Inc. company facts
Vanda Pharmaceuticals Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 921659108:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
5
Security
VNDA
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. | 8.1% | -47% | $20,206,904 | -$18,941,173 | 4,699,280 | -48% | BlackRock, Inc. | 31 Jan 2025 |
| AQR CAPITAL MANAGEMENT LLC | 5.8% | $20,986,170 | 3,497,695 | AQR Capital Management, LLC | 30 Jun 2026 | |||
| MILLENNIUM MANAGEMENT LLC | 5.6% | +93% | $19,751,946 | +$9,929,720 | 3,376,401 | +101% | Millennium Management LLC | 17 Aug 2026 |
| STATE STREET CORP | 5.1% | $20,837,533 | 3,015,562 | STATE STREET CORPORATION | 31 Mar 2026 | |||
| BlackRock Portfolio Management LLC | 4.2% | -22% | $17,333,652 | -$5,134,648 | 2,508,488 | -23% | BlackRock Portfolio Management LLC | 31 Mar 2026 |
As of 30 Jun 2026, 169 institutional investors reported holding 49,673,607 shares of Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share (VNDA). This represents 82% of the company’s total 60,292,875 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
69%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | 13% | 7,653,737 | +5.2% | 0% | $46,840,870 |
| STATE STREET CORP | 5.8% | 3,516,405 | +17% | 0% | $21,520,399 |
| AQR CAPITAL MANAGEMENT LLC | 5.8% | 3,497,695 | +118% | 0.01% | $21,405,893 |
| RENAISSANCE TECHNOLOGIES LLC | 5.7% | 3,441,361 | -8.5% | 0.03% | $21,061,129 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.2% | 2,524,040 | +1.7% | 0% | $15,447,125 |
| AIGH Capital Management LLC | 3.4% | 2,044,169 | -26% | 1.1% | $12,510,315 |
| ACADIAN ASSET MANAGEMENT LLC | 3.2% | 1,918,063 | +6.8% | 0.01% | $11,732,000 |
| DIMENSIONAL FUND ADVISORS LP | 2.9% | 1,727,349 | -2.5% | 0% | $10,572,544 |
| MILLENNIUM MANAGEMENT LLC | 2.7% | 1,602,813 | -15% | 0.01% | $9,809,216 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.5% | 1,483,787 | +2.8% | 0% | $9,082,993 |
| TWO SIGMA INVESTMENTS, LP | 2.2% | 1,349,072 | -3.5% | 0.01% | $8,256,321 |
| MARSHALL WACE, LLP | 2% | 1,225,996 | +106% | 0.01% | $7,503,094 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 2% | 1,213,326 | +3.8% | 0.03% | $7,425,555 |
| Krensavage Asset Management, LLC | 2% | 1,180,388 | 0% | 2.7% | $7,224,000 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1.9% | 1,131,034 | +11% | 0% | $6,921,928 |
| GOLDMAN SACHS GROUP INC | 1.7% | 1,036,260 | +24% | 0% | $6,341,911 |
| CITADEL ADVISORS LLC | 1.3% | 758,302 | +20% | 0% | $4,640,808 |
| Qube Research & Technologies Ltd | 1.2% | 729,212 | 0% | $4,462,777 | |
| FEDERATED HERMES, INC. | 1.2% | 714,278 | +24% | 0.01% | $4,371,381 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.1% | 646,256 | +17% | 0% | $3,955,087 |
| NORTHERN TRUST CORP | 1% | 600,619 | +33% | 0% | $3,675,788 |
| MORGAN STANLEY | 0.79% | 477,974 | +8.4% | 0% | $2,925,200 |
| Lionhunter Capital Management, LLC | 0.66% | 400,245 | 0% | 1.1% | $2,449,499 |
| VANGUARD FIDUCIARY TRUST CO | 0.66% | 399,817 | +3.1% | 0% | $2,446,880 |
| Jump Financial, LLC | 0.56% | 339,907 | +71% | 0.02% | $2,080,231 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
50
Latest
Q2 2026
Rows shown
1-25 of 50
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 49,673,607 | $303,993,447 | +$17,548,114 | $6.12 | 169 |
| 2026 Q1 | 46,226,361 | $319,434,847 | +$25,049,869 | $6.91 | 170 |
| 2025 Q4 | 41,919,677 | $369,634,945 | -$8,977,057 | $8.82 | 153 |
| 2025 Q3 | 44,885,173 | $223,975,088 | -$615,405 | $4.99 | 146 |
| 2025 Q2 | 45,005,222 | $212,432,729 | +$5,358,364 | $4.72 | 137 |
| 2025 Q1 | 43,925,314 | $201,682,351 | +$2,283,938 | $4.59 | 145 |
| 2024 Q4 | 43,147,771 | $206,663,421 | -$5,834,005 | $4.79 | 146 |
| 2024 Q3 | 43,981,766 | $206,261,308 | +$385,141 | $4.69 | 151 |
| 2024 Q2 | 43,532,710 | $245,988,772 | -$20,221,284 | $5.65 | 147 |
| 2024 Q1 | 48,062,202 | $197,420,430 | -$11,386,730 | $4.11 | 140 |
| 2023 Q4 | 50,696,953 | $213,770,549 | -$8,165,025 | $4.22 | 154 |
| 2023 Q3 | 52,588,884 | $227,183,918 | -$23,037,768 | $4.32 | 179 |
| 2023 Q2 | 56,248,075 | $370,694,666 | -$14,253,028 | $6.59 | 187 |
| 2023 Q1 | 58,308,583 | $395,914,559 | +$17,232,279 | $6.79 | 176 |
| 2022 Q4 | 55,589,814 | $410,808,616 | +$2,189,163 | $7.39 | 186 |
| 2022 Q3 | 55,141,714 | $544,810,424 | -$11,288,828 | $9.88 | 171 |
| 2022 Q2 | 56,006,392 | $610,516,173 | -$187,164 | $10.90 | 166 |
| 2022 Q1 | 56,272,506 | $636,565,420 | +$17,401,270 | $11.31 | 181 |
| 2021 Q4 | 54,252,447 | $851,181,026 | -$29,760,480 | $15.69 | 192 |
| 2021 Q3 | 55,224,691 | $946,649,896 | +$4,381,069 | $17.14 | 173 |
| 2021 Q2 | 54,791,110 | $1,178,013,080 | +$10,402,309 | $21.51 | 176 |
| 2021 Q1 | 54,541,422 | $819,510,471 | -$4,488,836 | $15.02 | 182 |
| 2020 Q4 | 55,039,795 | $723,395,120 | +$5,524,875 | $13.14 | 170 |
| 2020 Q3 | 54,414,204 | $525,712,121 | -$8,605,614 | $9.66 | 159 |
| 2020 Q2 | 55,140,491 | $630,777,920 | +$15,624,266 | $11.44 | 159 |